한국어
English
日本語
中文(简体)
Remicote Extended-Release Capsule 1mg (Emedastine Fumarate Extended-Release Granules)
155mg
Prescription medication
Kolon Pharmaceutical Co., Ltd.
Emedastine difumarate sustained-release granules are an antihistamine ingredient that alleviates allergy symptoms.
MFDS ingredient code M251127
Emedastine difumarate sustained-release granules belong to the class of antihistamines that block histamine receptors. They are primarily used in pharmaceuticals to relieve symptoms caused by allergic reactions. The sustained-release formulation allows for the slow release of the medication, providing a continuous effect.
This ingredient inhibits allergic reactions by blocking the receptors that histamine binds to in the body. When histamine cannot act, allergy symptoms such as sneezing, itching, and runny nose are reduced. The sustained-release formulation allows for prolonged effectiveness.
Approved uses differ by product. Check each product's information for its actual use.
Emedastine is known to cause less drowsiness compared to other antihistamines. The sustained-release formulation maintains a consistent blood concentration, which is advantageous for symptom control. This differentiates it from conventional formulations that are quickly absorbed and have a short duration of action.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
